The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase - An immunohistochemical study

Human Reproduction

Volumn 12, Issue 6, 1997, Pages 1293-1297

  Gemzell Danielsson, K ^a   Swahn, M L ^a   Bygdeman, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiprogestin; Endometrial receptivity; Implantation; LIF

Indexed keywords

CONTRACEPTIVE AGENT; LEUKEMIA INHIBITORY FACTOR; MIFEPRISTONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; NORMAL HUMAN; STROMA CELL;

EID: 0030967363     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.6.1293     Document Type: Article

References (24)

1. Arici, A., Engin, O., Attar, E. et al. (1995) Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. Clin. Endocrinol. Metab., 80, 1908-1915.
2. Batista, M.C., Cartledge, T.P., Zellmer, A.W. et al. (1992) Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486. A potential new contraceptive strategy. Am. J. Obstet. Gynecol., 167, 60-65.
3. Cameron, ST., Critchley, H.O.D. and Baird, D.T. (1996) Immunolocalisation of leukaemia inhibitory factor in secretry endometrium after antiprogestins. Abstract F5, 4th European Congress on Prostaglandins and Other Locally Active Factors in Reproduction, Stockholm, Sweden, May 22-25.
4. Cekan, S.Z., Beksac, M.S., Wang, E. et al. (1986) The prediction and/or detection of ovulation by means of urinary steroid assay. Contraception, 33, 327-345.
5. Charnock-Jones, D., Sharkey, A., Fenwick, P. et al. (1994) Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. Reprod. Fertil, 101, 421-426.
6. Chen, D-B., Hilsenrath, R., Yang, Z.-M. et al. (1995) Leukaemia inhibitory factor in human endometrium during the menstrual cycle: cellular origin and action on production of glandular epithelial cell prostaglandin in vitro. Hum. Reprod., 10, 911-918.
7. Croxatto, H.B., Salvatierra, A.M., Croxatto, H.D. and Fuentealba, B. (1993) Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum. Reprod., 8, 201-207.
8. Gemzell Danielsson, K., Svalander, P., Swahn, M.L. et al. (1994) Effects of a single, post-ovulatory dose of RU 486 on endometrial maturation in the implantation phase. Hum. Reprod., 9, 2398-2904.
9. Gemzell Danielsson, K., Swahn, M.-L., Westlund, P. et al. (1997) Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum. Reprod, 12, 124-131.
10. Gemzell Danielsson, K. and Hamberg, M. (1994) The effect of antiprogestin (RU 486) and prostaglandin biosythesis inhibitor (naproxen) on uterine fluid prostaglandin F2α concentrations. Hum. Reprod., 9, 1626-1630.
11. Gemzell Danielsson, K., Swahn, M.L., Svalander, P. and Bygdeman, M. (1993) Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum. Reprod., 8, 870-873.
12. Gemzell Danielsson, K., Westlund, P., Swahn, M.L. et al. (1996) Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 11, 256-264.
13. Giudice, L.C. (1994) Growth factors and growth hormone modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil. Steril., 61, 1-17.
14. Johannisson, E., Landgren, B.M., Rohr, H.P. and Diczfalusy, E. (1987) Endometrial morphology and peripheral hormone levels in women with regular menstrual cycles. Fertil. Steril., 48, 401-408.
15. Ledger, W.L., Sweeting, V.M., Hillier, H. and Baird, D.T. (1992) Inhibition of ovulation by low-dose mifepristone (RU 486). Hum. Reprod., 7, 945-950.
16. Mäentausta, O., Svalander, P., Gemzell Danielsson, K. et al. (1993) The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17β-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. J. Clin. Endocrinol. Metab., 77, 913-918.
17. Metcalf, M.G. and Hunt, E.G. (1976) Calculation of estrogen excretion rates from urinary estrogen to creatine ratios. Clin. Biochem., 8, 75-77.
18. Sawai, K., Matsuzaki, N., Kameda, T. et al. (1995) Leukemia inhibitory factor produced at the fetomaternal interface stimulates chorionic gonadotropin production: its possible implication during pregnancy, including implantation period. J. Clin. Endocrinol. Metab., 80, 1449-1456.
19. Simón, C., Frances, A., Piquette, G.N. et al. (1994a) Embryonic implantation in mice is blocked by Interleukin-1 receptor antagonist (IL-Ira). Endocrinology, 134, 521-528.
20. Simón, C., Piquette, G.N., Frances, A. et al. (1994b) The effect of Interleukin-1 beta (IL-1β) on the regulation of IL-1 receptor type I and IL-1 beta messenger ribonucleic acid (mRNS) levels and protein expression in cultured human endometrial stromal and glandular cells. J. Clin. Endocrinol. Metab., 78, 675-672.
21. Simón, C., Gimeno, M.J., Mercader, A., Frances, A. et al. (1996) Cytokines-adhesion molecules-invasive proteinases. The missing paracrine/autocrine link in embryonic implantation? Mol. Hum. Reprod., 2, 405-424.
22. Stewart, C.L., Kaspar, P., Brunet, L.J. et al. (1992) Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature, 359, 76-79.
23. Swahn, M.L., Bygdeman, M., Cekan, S. et al. (1990) The effects of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum. Reprod., 5, 402-408.
24. Tabibzadeh, S. (1995) Signals and molecular pathways involved in apoptosis, with special emphasis on human endometrium. Hum. Reprod. Update, 1, 303-323.